Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Hepatocellular × tazemetostat × 30 days × Clear all

Sponsor

Conditions

Lymphoma, Follicular 2 Urinary Bladder Neoplasms 1 Tertiary Lymphoid Structures 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Melanoma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell 1 Leukemia, Myeloid, Acute 1 Colorectal Neoplasms 1 Carcinoma, Transitional Cell 1

Interventions

Bevacizumab 13 atezolizumab 12 Specimen Handling 9 Nivolumab 8 durvalumab 6 pembrolizumab 4 X-Rays 4 Radiosurgery 4 Magnetic Resonance Spectroscopy 4 Ipilimumab 4 lenvatinib 3 Sorafenib 3 Immunoglobulin G 3 E-7386 3 Cyclophosphamide 3 Blood Specimen Collection 3 sintilimab 2 regorafenib 2 cabozantinib 2 Disulfides 2 Biopsy 2 tremelimumab 1 tislelizumab 1 sofosbuvir-velpatasvir drug combination 1 sargramostim 1 sapanisertib 1 rocakinogene sifuplasmid 1 relatlimab 1 recombinant interferon alpha 2b-like protein 1 fludarabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡